Literature DB >> 8621406

A di-leucine motif and an upstream serine in the interleukin-6 (IL-6) signal transducer gp130 mediate ligand-induced endocytosis and down-regulation of the IL-6 receptor.

E Dittrich1, C R Haft, L Muys, P C Heinrich, L Graeve.   

Abstract

The interleukin-6 (IL-6) receptor complex is composed of two different subunits, the IL-6 binding protein (IL-6R, gp80) and the signal transducing component gp130. Our previous studies revealed that the 10-amino acid sequence TQPLLDSEER within the intracellular domain of gp130 is crucial for the efficient internalization of IL-6. Since this sequence contains a putative di-leucine internalization motif, we further analyzed this region by constructing two additional deletions and a series of point mutants. Analyses of these mutants showed that the di-leucine pair (Leu-145 and Leu-146) is essential for ligand internalization, with leucine 145 being less resilient to exchanges. Furthermore, when a chimeric protein (Tac-STQPLL) composed of the Tac antigen fused to the hexapeptide STQPLL of gp130 was studied, we found that this sequence is sufficient to mediate endocytosis and lysosomal targeting of the chimera. Mutational analysis of three serine residues upstream of the di-leucine motif revealed that mutation of serine 139 to an alanine reduces the initial internalization rate by 50%. This finding suggests that a serine phosphorylation may be important for rapid endocytosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621406     DOI: 10.1074/jbc.271.10.5487

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Structural requirements of the interleukin-6 signal transducer gp130 for its interaction with Janus kinase 1: the receptor is crucial for kinase activation.

Authors:  Claude Haan; Peter C Heinrich; Iris Behrmann
Journal:  Biochem J       Date:  2002-01-01       Impact factor: 3.857

2.  A C-terminal tyrosine-based motif in the bile salt export pump directs clathrin-dependent endocytosis.

Authors:  Ping Lam; Shuhua Xu; Carol J Soroka; James L Boyer
Journal:  Hepatology       Date:  2012-04-25       Impact factor: 17.425

Review 3.  Biology and significance of the JAK/STAT signalling pathways.

Authors:  Hiu Kiu; Sandra E Nicholson
Journal:  Growth Factors       Date:  2012-02-20       Impact factor: 2.511

4.  Regulation of neurokine receptor signaling and trafficking.

Authors:  Neil M Nathanson
Journal:  Neurochem Int       Date:  2012-01-25       Impact factor: 3.921

5.  Scale-up of a physiologically-based pharmacokinetic model to predict the disposition of monoclonal antibodies in monkeys.

Authors:  Patrick M Glassman; Yang Chen; Joseph P Balthasar
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-09-12       Impact factor: 2.745

6.  The adaptor TRAF5 limits the differentiation of inflammatory CD4(+) T cells by antagonizing signaling via the receptor for IL-6.

Authors:  Hiroyuki Nagashima; Yuko Okuyama; Atsuko Asao; Takeshi Kawabe; Satoshi Yamaki; Hiroyasu Nakano; Michael Croft; Naoto Ishii; Takanori So
Journal:  Nat Immunol       Date:  2014-03-30       Impact factor: 25.606

Review 7.  Eliminative signaling by Janus kinases: role in the downregulation of associated receptors.

Authors:  Christopher J Carbone; Serge Y Fuchs
Journal:  J Cell Biochem       Date:  2014-01       Impact factor: 4.429

Review 8.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Authors:  P C Heinrich; I Behrmann; G Müller-Newen; F Schaper; L Graeve
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

9.  Dileucine and YXXL motifs in the cytoplasmic tail of the bovine leukemia virus transmembrane envelope protein affect protein expression on the cell surface.

Authors:  Sinisa Novakovic; Earl T Sawai; Kathryn Radke
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

10.  Role of the carboxyl terminal di-leucine in phosphorylation and internalization of C5a receptor.

Authors:  Elena S Suvorova; Jeannie M Gripentrog; Martin Oppermann; Heini M Miettinen
Journal:  Biochim Biophys Acta       Date:  2008-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.